sparfloxacin   Click here for help

GtoPdb Ligand ID: 10860

Synonyms: AT-4140 | AT4140 | CI-978 | CI978 | SPFX | Zagam ®
Approved drug
sparfloxacin is an approved drug (FDA (1996))
Compound class: Synthetic organic
Comment: Sparfloxacin is a fluoroquinolone antibacterial. It has a less than ideal side-effect profile [3] that led to its withdrawl from the US market.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 5
Hydrogen bond donors 3
Rotatable bonds 3
Topological polar surface area 100.59
Molecular weight 392.17
XLogP 4.1
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES C[C@@H]1N[C@H](C)CN(C1)c1c(F)c(N)c2c(c1F)n(cc(c2=O)C(=O)O)C1CC1
Isomeric SMILES C[C@@H]1N[C@H](C)CN(C1)c1c(F)c(N)c2c(c1F)n(cc(c2=O)C(=O)O)C1CC1
InChI InChI=1S/C19H22F2N4O3/c1-8-5-24(6-9(2)23-8)17-13(20)15(22)12-16(14(17)21)25(10-3-4-10)7-11(18(12)26)19(27)28/h7-10,23H,3-6,22H2,1-2H3,(H,27,28)/t8-,9+
InChI Key DZZWHBIBMUVIIW-DTORHVGOSA-N
References
1. Domagala JM, Bridges AJ, Culbertson TP, Gambino L, Hagen SE, Karrick G, Porter K, Sanchez JP, Sesnie JA, Spense FG et al.. (1991)
Synthesis and biological activity of 5-amino- and 5-hydroxyquinolones, and the overwhelming influence of the remote N1-substituent in determining the structure-activity relationship.
J Med Chem, 34 (3): 1142-54. [PMID:1848296]
2. Ohtsuka M, Kikuchi K, Shimizu K, Takahashi N, Ono Y, Sasaki T, Hiramatsu K. (2009)
Emergence of quinolone-resistant Bordetella pertussis in Japan.
Antimicrob Agents Chemother, 53 (7): 3147-9. [PMID:19414571]
3. Psaty BM. (2008)
Clinical trial design and selected drug safety issues for antibiotics used to treat community-acquired pneumonia.
Clin Infect Dis, 47 Suppl 3: S176-9. [PMID:18986285]